Clinical Trial

Assessment of the Axone Micro Quadripolar Lead for Enhanced Cardiac Resynchronization Therapy

Study acronym: ASTRAL-4LV
Active, Not Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated January 5, 2024 (before its estimated June 2024 completion). Its status may not reflect the trial's current state.
Summary
The primary objective of this study is to assess the chronic safety and performance of the Axone left ventricular (LV) micro-lead.
Protocol Amendment History 5 amendments
This ClinicalTrials.gov record has been amended 5 times since 2020-07-03; most recent amendment 2024-01-03.
Status change: Recruiting → Active, Not Recruiting 2024-01-03
Status change: Not Yet Recruiting → Recruiting 2021-01-08
Trial Details
NCT Number NCT04463641
Lead Sponsor MicroPort CRM
Conditions Heart Failure, Cardiac Resynchronization Therapy
Enrollment 92 participants
Start Date 2020-12-03
Primary Completion 2024-06 (estimated)
Study Completion 2027-12 (estimated)
Updated on ClinicalTrials.gov 2024-01-05